Multiple Myeloma
Multiple Myeloma Treatment Outcomes and Physician–Patient Side Effect Concordance
A recent study found that higher side-effect bother was related to worse health-related quality of life in multiple myeloma patients. The study also found patient–physician discordance in reporting of side effects. Multiple myeloma (MM) is the second most prevalent hematological malignancy in the United States. Evidence shows that physicians focus on survival outcomes when making...
Top 7 Latest Advances in Multiple Myeloma
The field of multiple myeloma (MM) treatment has seen significant advancements in recent years, which have improved median survival rates for patients from 3 years two decades ago to around 10 years now. One of the most notable advancements in the treatment of MM is the introduction of immune-based therapies, specifically anti-CD38 monoclonal antibodies. These...
Multiple Myeloma: Overcoming Gaps in Treatment and Overcoming Disparities
In this exclusive MD Newsline webcast Hematology-Oncology Specialists Dr. Mouhammed Kelta and Dr. Shaina Rozell discuss health disparities in Multiple Myeloma.
Multiple Myeloma: Empowering Patients & Doctors
Question: If a hospital is not equipped to do that study, how do doctors advocate for that? What kind of strategies have you seen to make sure those patients get care? And How can patients advocate for themselves to make sure that they get the proper tests that they need? Answer: So it really is...
Understanding Multiple Myeloma: Treatment Gaps, Racial Disparities, and Early Diagnosis
Intro: Hi everyone. My name is Shaina Rozell. I’m a hematologist-oncologist here with Affiliated Oncology. I also practice out of Advocate Christ as well as Advocate South Suburban. My emphasis is both hematology and oncology so I see multiple myeloma. I run a genetics clinic at Advocate Christ and also am very instrumental in our...
Multiple Myeloma: Early Signs and Key Symptoms
Question: So how does multiple myeloma typically start? At which point in that journey do the people who are most impacted end up in front of a doctor? Answer: I would say those patients who actually seek care or who actually go to the doctor may be getting blood tests. And that astute position may...
What Is the First Sign of Multiple Myeloma?
Multiple Myeloma is a type of cancer that impacts the plasma cells in the bone marrow. It is characterized by the proliferation and multiplication of these cells resulting in the production of antibodies that can potentially harm various systems within the body. Diagnosing this cancer can be quite complex because its symptoms tend to manifest...
Efficacy of Cilta-Cel Versus Standard Therapy in Lenalidomide-Refractory Multiple Myeloma
Medically reviewed by Dr. Shani S. Saks, D.O. on August 2, 2023 In a phase 3 trial, ciltacabtagene autoleucel caused a significantly lower risk of disease progression or death than standard care in lenalidomide-refractory multiple myeloma patients. The frequency of lenalidomide resistance early in multiple myeloma (MM) treatment is increasing, leading to a need for...
Teclistamab in Relapsed or Refractory Multiple Myeloma
Medically reviewed by Dr. Shani S. Saks, D.O. on August 2, 2023 Patients in a phase 1–2 study who were treated with teclistamab demonstrated a high rate of durable and deep therapeutic response. The treatment was safe and effective. Most of the toxic effects that were associated with T-cell redirection were categorized as grade 1...
More Medical News
